Literature DB >> 8099456

Thymic epithelial tumours: evaluation of malignant grade by quantification of proliferating cell nuclear antigen and nucleolar organizer regions.

H Tateyama1, T Mizuno, T Tada, T Eimoto, T Hashimoto, A Masaoka.   

Abstract

Cellular proliferation was studied by quantification of proliferating cell nuclear antigen (PCNA) and argyrophilic nucleolar organizer regions (AgNORs) of cells in 29 thymic epithelial tumours: 8 noninvasive (7 cortical and 1 mixed) thymomas, 11 invasive/metastatic (all cortical) thymomas, and 10 thymic carcinomas. Thymic carcinoma showed the highest percentage of cells positive for PCNA (14.73 +/- 5.419%) and the largest mean number of AgNORs per nucleus (4.89 +/- 0.756). The mean percentage of PCNA-positive cells and number of AgNORs in thymoma groups were as follows: in noninvasive thymoma 2.96 +/- 1.256% and 2.73 +/- 0.647, respectively, and in invasive/metastatic thymoma 4.41 +/- 1.823% and 3.68 +/- 1.148, respectively. The differences in PCNA and AgNORs were statistically significant between thymic carcinoma and each of thymoma groups. The overlap of the values between these tumours was minimal in the PCNA stains, although it was considerable in AgNOR counts as previously noted. However, there was no statistically significant difference in these markers between noninvasive and invasive/metastatic thymomas. These results indicate that thymoma in general is a slow-growing tumour compared with thymic carcinoma and that noninvasive thymoma is similar to invasive/metastatic thymoma with regard to proliferative activity; these latter two tumours may represent an essentially identical type in different stages of progression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099456     DOI: 10.1007/bf01608334

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  27 in total

1.  Nucleolar organiser regions in hyperplastic and neoplastic prostatic tissue.

Authors:  A B Hansen; B Ostergård
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.

Authors:  D Ploton; M Menager; P Jeannesson; G Himber; F Pigeon; J J Adnet
Journal:  Histochem J       Date:  1986-01

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

Review 4.  The nucleolar organizer regions.

Authors: 
Journal:  Biol Cell       Date:  1983       Impact factor: 4.458

5.  Breast carcinoma kinetics. Argyrophilic nucleolar organizer region counts correlate with Ki67 scores.

Authors:  P A Dervan; L G Gilmartin; B M Loftus; D N Carney
Journal:  Am J Clin Pathol       Date:  1989-10       Impact factor: 2.493

6.  Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta.

Authors:  R Bravo; R Frank; P A Blundell; H Macdonald-Bravo
Journal:  Nature       Date:  1987 Apr 2-8       Impact factor: 49.962

7.  Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies.

Authors:  B A Robbins; D de la Vega; K Ogata; E M Tan; R M Nakamura
Journal:  Arch Pathol Lab Med       Date:  1987-09       Impact factor: 5.534

8.  Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication.

Authors:  K Ogata; P Kurki; J E Celis; R M Nakamura; E M Tan
Journal:  Exp Cell Res       Date:  1987-02       Impact factor: 3.905

9.  Thymic carcinoma. A clinicopathologic study of 60 cases.

Authors:  S Suster; J Rosai
Journal:  Cancer       Date:  1991-02-15       Impact factor: 6.860

Review 10.  Nucleolar organiser regions in pathology.

Authors:  M J Egan; J Crocker
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

View more
  5 in total

1.  Proliferative cell nuclear antigen expression in follicular tumours of the thyroid with special reference to oxyphilic cell lesions.

Authors:  H Tateyama; Y P Yang; T Eimoto; T Tada; H Inagaki; T Nakamura; H Iwase; S Kobayashi
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

2.  Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen.

Authors:  N E Gilhus; M Jones; H Turley; K C Gatter; N Nagvekar; J Newsom-Davis; N Willcox
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

3.  Clinicopathological analysis of small-sized thymoma with podoplanin and Ki 67 expression analysis.

Authors:  Keisuke Yokota; Hisashi Tateyama; Motoki Yano; Satoru Moriyama; Yu Hikosaka; Katsuhiro Okuda; Masayuki Shitara; Meinoshin Okumura; Kohei Yokoi; Yoshitaka Fujii
Journal:  Mol Clin Oncol       Date:  2012-06-08

4.  Expression patterns for Bcl-2, EMA, β-catenin, E-cadherin, PAX8, and MIB1 in thymomas.

Authors:  David Suster; James A Miller; German Pihan; A Craig Mackinnon; Saul Suster
Journal:  Mod Pathol       Date:  2021-06-16       Impact factor: 7.842

5.  Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization.

Authors:  Gui Youn Lee; Woo Ick Yang; Hei Cheul Jeung; Sang Chul Kim; Min Young Seo; Chan Hee Park; Hyun Cheol Chung; Sun Young Rha
Journal:  BMC Genomics       Date:  2007-09-03       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.